Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
The SETIA program examined the economic impact of typhoid illness and evaluated the potential value of introducing typhoid conjugate vaccine (TCV) into Indonesia’s National Immunisation Program. A multisite cost-of-illness study estimated the direct and indirect costs associated with typhoid
Our study aims to assess the immune responses of two different fourth-dose vaccines (bivalent Moderna versus Novavax) among people who have previously received three doses of a COVID-19 vaccine.
Using AI and large online data to dynamically track vaccine myths and concerns online, to support doctors and communities in staying ahead with clear, trustworthy facts. Disinformation and misinformation about vaccines is becoming a big problem around the world. VaxPulse is a system that uses
This study is complete. Mild Matters is a research project which aims to find out if hearing aids can help babies and young children with bilateral mild hearing loss.
This study is complete. This project involved an extra test for babies who do not pass their second hearing screen. This extra test uses a sample of the baby’s mouth saliva (spit) to see if there was a virus (germ) called cytomegalovirus (CMV) present at the time of their birth.
Auditory neuropathy is a type of hearing loss that can have a genetic cause. This study aims to gain a better understanding of the natural course of hearing loss caused by changes in the otoferlin gene.
VicCHILD is the Victorian Childhood Hearing Longitudinal Databank. It collects different information from children and their families to create a unique resource for advancing research in hearing loss.
We are developing a fast and accurate bedside test to detect congenital Cytomegolovirus (cCMV) cost effectively in the first weeks of life. We understand that cCMV may be treatable in some cases if detected in the first month of life.
This Australian-led study is the world’s largest international trial on the off-target effects of Bacille Calmette-Guérin (BCG) vaccine.
This study aims to assess the long-term effectiveness of a single dose of the quadrivalent HPV (4vHPV) vaccine against HPV in Fijian women approximately 17 years following the HPV vaccination campaign conducted in 2008/2009.
Page 35 of 188
